Skip to main content
Top
Published in: BMC Oral Health 1/2023

Open Access 01-12-2023 | Lichen Planus | Research

Changes in the Oral-Health-Related Quality of Life of Thai patients with oral lichen planus after topical corticosteroid treatment: a 1-month longitudinal study

Authors: Witchapat Kengtong, Pornpan Piboonratanakit, Sudaduang Krisdapong

Published in: BMC Oral Health | Issue 1/2023

Login to get access

Abstract

Background

Oral lichen planus (OLP) is a chronic inflammatory disease of the oral cavity that affects many patients’ daily living activities. Topical corticosteroids are the first-line drug for treating OLP. The Oral Impact on Daily Performances index (OIDP) is an Oral-Health-Related Quality of Life (OHRQoL) measure developed to assess the ultimate impacts. The aims of this study were to evaluate the clinical, pain and OHRQoL responses after treating OLP patients with topical corticosteroids for 1 month, and secondly to assess the relationships of changes in the clinical sign score, pain score, and OHRQoL.

Methods

Seventy-two OLP patients were treated by topical corticosteroids based on their dentists’ clinical judgments. Clinical and patient-based outcomes were assessed at baseline and follow-up visit. The clinical outcomes were evaluated by the highest and total Thongprasom sign score. Patient-based outcomes were evaluated by numeric rating scale (NRS) and OIDP. The self-rated overall changes in quality of life during the 1-month treatment period using the Patient Global Impression of Change (PGIC) were also recorded at the follow-up visit.

Results

This study comprised 59 women and 13 men. All clinical and patient-based outcomes were significantly reduced after 1-month treatment with topical corticosteroids (P < 0.01). The most commonly affected activities were Emotional stability, followed by Eating and Cleaning the oral cavity. Forty-six percent reported the same or up to moderately improved, while 54% had a greatly improved quality of life as assessed by PGIC. There were no significant differences in the improvement of clinical and patient-based outcomes between these groups. There were significant relationships between the differences in the highest Thongprasom sign score and the differences in total Thongprasom sign score (r = 0.293; P < 0.05), and the differences in total OIDP percentage score and the difference in pain score (r = 0.427; P < 0.001). The differences in the total Thongprasom sign score also significantly related to the difference in the total OIDP percentage score (r = 0.335; P < 0.01).

Conclusions

Topical corticosteroids were significantly effective after 1-month treatment of OLP based on the clinical and patient-based outcomes. The OHRQoL improvement was significantly related to the reductions in pain and clinical severity.

Trial registration

The trial was registered at the Thai Clinical Trials Registry (TCTR identifier: TCTR 20221110001).
Literature
6.
11.
go back to reference Santonocito S, Polizzi A, De Pasquale R, Ronsivalle V, Lo Giudice A, Isola G. Analysis of the efficacy of two treatment protocols for patients with symptomatic oral lichen planus: a randomized clinical trial. Int J Environ Res Public Health. 2021;18(1):56. https://doi.org/10.3390/ijerph18010056.CrossRef Santonocito S, Polizzi A, De Pasquale R, Ronsivalle V, Lo Giudice A, Isola G. Analysis of the efficacy of two treatment protocols for patients with symptomatic oral lichen planus: a randomized clinical trial. Int J Environ Res Public Health. 2021;18(1):56. https://​doi.​org/​10.​3390/​ijerph18010056.CrossRef
14.
go back to reference Brennan MT, Madsen LS, Saunders DP, Napenas JJ, McCreary C, Ni Riordain R, Pedersen AML, Fedele S, Cook RJ, Abdelsayed R. Efficacy and safety of a novel mucoadhesive clobetasol patch for treatment of erosive oral lichen planus: a phase 2 randomized clinical trial. J Oral Pathol Med. 2022;51(1):86–97. https://doi.org/10.1111/jop.13270.CrossRefPubMed Brennan MT, Madsen LS, Saunders DP, Napenas JJ, McCreary C, Ni Riordain R, Pedersen AML, Fedele S, Cook RJ, Abdelsayed R. Efficacy and safety of a novel mucoadhesive clobetasol patch for treatment of erosive oral lichen planus: a phase 2 randomized clinical trial. J Oral Pathol Med. 2022;51(1):86–97. https://​doi.​org/​10.​1111/​jop.​13270.CrossRefPubMed
16.
go back to reference Hegarty A, Hodgson T, Lewsey J, Porter S. Fluticasone propionate spray and betamethasone sodium phosphate mouthrinse: a randomized crossover study for the treatment of symptomatic oral lichen planus. J Am Acad Dermatol. 2002;47(2):271–9.CrossRefPubMed Hegarty A, Hodgson T, Lewsey J, Porter S. Fluticasone propionate spray and betamethasone sodium phosphate mouthrinse: a randomized crossover study for the treatment of symptomatic oral lichen planus. J Am Acad Dermatol. 2002;47(2):271–9.CrossRefPubMed
18.
19.
go back to reference Adulyanon S. Oral impacts on daily performances. Measuring Oral Health and Quality of Life. 1997. pp.151–60. Adulyanon S. Oral impacts on daily performances. Measuring Oral Health and Quality of Life. 1997. pp.151–60.
21.
25.
32.
go back to reference Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, Axéll T, Bruce AJ, Carpenter W, Eisenberg E. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:S25. e21-S25. e12. https://doi.org/10.1016/j.tripleo.2006.11.001. Al-Hashimi I, Schifter M, Lockhart PB, Wray D, Brennan M, Migliorati CA, Axéll T, Bruce AJ, Carpenter W, Eisenberg E. Oral lichen planus and oral lichenoid lesions: diagnostic and therapeutic considerations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103:S25. e21-S25. e12. https://​doi.​org/​10.​1016/​j.​tripleo.​2006.​11.​001.
Metadata
Title
Changes in the Oral-Health-Related Quality of Life of Thai patients with oral lichen planus after topical corticosteroid treatment: a 1-month longitudinal study
Authors
Witchapat Kengtong
Pornpan Piboonratanakit
Sudaduang Krisdapong
Publication date
01-12-2023
Publisher
BioMed Central
Keyword
Lichen Planus
Published in
BMC Oral Health / Issue 1/2023
Electronic ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-023-03603-w

Other articles of this Issue 1/2023

BMC Oral Health 1/2023 Go to the issue